COSMO PHARMACEUT. EO-,26/ NL0011832936 /
9/2/2024 8:20:14 PM | Chg. +0.50 | Volume | Bid8:20:14 PM | Ask8:20:14 PM | Market Capitalization | Dividend Y. | P/E Ratio |
---|---|---|---|---|---|---|---|
84.00EUR | +0.60% | - Turnover: - |
84.00Bid Size: - | 85.50Ask Size: - | 1.38 bill.EUR | 2.36% | 1,195.28 |
Assets
2015 IFRS in mill. EUR |
2016 IFRS in mill. EUR |
2017 IFRS in mill. EUR |
2018 IFRS in mill. EUR |
2019 IFRS in mill. EUR |
|||||||
---|---|---|---|---|---|---|---|---|---|---|---|
Property and Equipment | 21.1000 | 20.7000 | 30.2000 | 28.6000 | 30.2000 | ||||||
Intangible Assets | 4.5000 | 19.5000 | 28.5000 | 35.5000 | 49.2000 | ||||||
Long-Term Investments | 127.1000 | 72 | 93.8000 | 41.9000 | 53.9000 | ||||||
Fixed Assets | 300 | 256.4000 | 300.7000 | 251.5000 | 282.8000 | ||||||
Inventories | 2.2000 | 2.3000 | 3.2000 | 3.9000 | 6.1000 | ||||||
Accounts Receivable | 16.8000 | 15 | 13.2000 | 12.8000 | 16.5000 | ||||||
Cash and Cash Equivalents | 71.3000 | 117.6000 | 144.9000 | 210.7000 | 110.4000 | ||||||
Current Assets | 137.9000 | 187.1000 | 197.3000 | 374.2000 | 302.4000 | ||||||
Total Assets | 437.9000 | 443.5000 | 498 | 625.7000 | 585.2000 |
Liabilities
2015 IFRS in mill. EUR |
2016 IFRS in mill. EUR |
2017 IFRS in mill. EUR |
2018 IFRS in mill. EUR |
2019 IFRS in mill. EUR |
|||||||
---|---|---|---|---|---|---|---|---|---|---|---|
Accounts Payable | 4.3000 | 6.1000 | 11.3000 | 8.8000 | 7.8000 | ||||||
Long-term debt | 6.6000 | 4.5000 | 3.8000 | 157.6000 | 163.3000 | ||||||
Liabilities to Banks | 8.2000 | 5.3000 | 4.4000 | 158.1000 | 164.8000 | ||||||
Provisions | 2.3000 | 4.3000 | 4.3000 | 7.5000 | 8.8000 | ||||||
Liabilities | 34.3000 | 27.9000 | 27.9000 | 180.8000 | 191.4000 | ||||||
Share Capital | 3.7000 | 3.7000 | 3.9000 | 3.9000 | 3.9000 | ||||||
Total Equity | 403.6000 | 415.5000 | 470.1000 | 444.9000 | 393.7000 | ||||||
Minority Interests | 0.0000 | 0.0000 | 0.0000 | 0.0000 | 0.0000 | ||||||
Total liabilities equity | 437.9000 | 443.5000 | 498 | 625.7000 | 585.2000 |
Income Statement
2015 IFRS in mill. EUR |
2016 IFRS in mill. EUR |
2017 IFRS in mill. EUR |
2018 IFRS in mill. EUR |
2019 IFRS in mill. EUR |
|||||||
---|---|---|---|---|---|---|---|---|---|---|---|
Revenues | 60.6000 | 67.7000 | 67.2000 | 65.6000 | 62.5000 | ||||||
Depreciation (total) | - | - | - | - | - | ||||||
Operating Result | -7.5000 | 21 | -15.5000 | -16.6000 | -12.3000 | ||||||
Interest Income | - | - | - | - | - | ||||||
Income Before Taxes | -261.3000 | 27.5000 | -32.4000 | -17.5000 | -21.2200 | ||||||
Income Taxes | -6.1000 | -8.2000 | 0.0000 | -.6000 | -3.2000 | ||||||
Minority Interests Profit | 0.0000 | 0.0000 | 0.0000 | 0.0000 | 0.0000 | ||||||
Net Income | 248.2000 | 19.3000 | -32.4000 | -18 | -24.4000 |
Per Share
Cash Flow
2015 IFRS in mill. EUR |
2016 IFRS in mill. EUR |
2017 IFRS in mill. EUR |
2018 IFRS in mill. EUR |
2019 IFRS in mill. EUR |
|||||||
---|---|---|---|---|---|---|---|---|---|---|---|
Cash Flow from Operating Activities | -39.2000 | 26.4000 | -10 | -16.2000 | -17.6000 | ||||||
Cash Flow from Investing Activities | 78.9000 | 40.2000 | -22.3000 | -71.8000 | -48.7000 | ||||||
Cash Flow from Financing | -2.6000 | -22.6000 | 72.7000 | 144.4000 | -34.5000 | ||||||
Decrease / Increase in Cash | 37.1000 | 46.4000 | 40.4000 | 62.4000 | -102 | ||||||
Employees | 183 | 217 | 301 | 306 | 234 |